Adaptin Bio (APTN) Non Operating Income (2024 - 2026)

Adaptin Bio has disclosed Non Operating Income across 3 years of filings, most recently posting -$1943.0 for Q1 2026.

• Quarterly Non Operating Income fell 100.79% year-over-year to -$1943.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1943.0 (up 99.27% YoY) and the FY2025 annual result came in at $247374.0, up 144.76% from the prior year.
• Non Operating Income declined to -$1943.0 in Q1 2026, from $247374.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $247374.0 in Q1 2025 and bottomed at -$348756.0 in Q4 2024.
• The 3-year median for Non Operating Income is -$45557.0 (2024), against an average of -$51206.8.
• Year-over-year, Non Operating Income soared 723.17% in 2025 and slumped 100.79% in 2026.
• Adaptin Bio's Non Operating Income stood at -$348756.0 in 2024, then soared by 170.93% to $247374.0 in 2025, then tumbled by 100.79% to -$1943.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered -$1943.0, $247374.0, and -$348756.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.